Thereaputic efficacy of single dose Albendazole against Ascaris lumbricoides, prevalence of re-infection, and its associated factors among school children at Northwest Ethiopia: an open-label trial study

Abstract Background Despite extensive implementation of albendazole (ALB) mass drug administration to reduce Ascaris lumbricoides among school childrens, it remains a major chilhood health concern which needs close monitoring of ALB efficacy. Additionally, ALB donot prevent re-infection, and determi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hana Misganaw, Mebratu Tamir, Yalewayker Tegegne, Zufan Yiheyis Abriham, Dereje Mengesha Berta, Bisrat Birke Teketelew, Negesse Cherie, Tsedenya Gebeyehu, Elias Chane, Abiy Ayele Angelo, Aberham Abere, Abebaw Setegn, Tegegne Eshetu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2026-01-01
Saila:	BMC Infectious Diseases
Gaiak:	Albendazole Ascaris lumbricoides Northwest Ethiopia
Sarrera elektronikoa:	https://doi.org/10.1186/s12879-026-12644-9
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!